Indeed, loss-of-function variants in EPHB4 and RASA1 affect the EPHB4-RAS-ERK signaling pathway (1) and gene variants in HHT, the TGF-β/BMP signaling pathway (28) with molecular differences between all the proteins. The gene discussed is RASA1; the disease is hereditary hemorrhagic telangiectasia.